ALDOA

ALDOA Full Name

aldolase A, fructose-bisphosphate

ALDOA Introduction

Aldolase A (fructose-bisphosphate aldolase A) is a ubiquitously expressed glycolytic enzyme that catalyzes the reversible cleavage of fructose-1,6-bisphosphate (FBP) into dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (G3P). As the predominant aldolase isoform in muscle and most non-hepatic tissues, ALDOA plays an essential role in glycolysis, providing metabolic intermediates for ATP production, gluconeogenesis, and lipid synthesis. Unlike the liver-specific isoform ALDOB, which efficiently cleaves both FBP and fructose-1-phosphate (F1P), ALDOA exhibits strong substrate specificity for FBP with minimal activity against F1P. ALDOA is highly expressed in skeletal muscle, cardiac muscle, brain, and red blood cells, where its high catalytic efficiency supports rapid glucose flux. Deficiency of aldolase A causes a rare but serious autosomal recessive disorder characterized by hemolytic anemia, myopathy, and occasionally intellectual disability. Beyond its canonical glycolytic function, ALDOA has emerged as a multifunctional protein involved in cell proliferation, cytoskeletal organization, gene expression, and cancer metabolism, making it a subject of intensive research.

Figure 1. Schematic structure of ALDOA.

Expression and Biochemical Characteristics
ALDOA exhibits widespread expression across nearly all tissues, with highest levels in skeletal muscle, cardiac muscle, and brain—tissues with high energy requirements. The enzyme is a cytoplasmic protein that functions in a metal-dependent manner, utilizing magnesium ions to drive the cleavage of fructose-1,6-bisphosphate with high specificity. Multiple transcript variants of ALDOA have been identified, encoding distinct isoforms that allow for tissue-specific regulation of its expression and catalytic activity. Its biochemical structure features a conserved active site that enables precise recognition of its glycolytic substrate, and it forms tetramers to maintain optimal catalytic efficiency, underscoring its role as a foundational metabolic enzyme.

Isoforms and Genetic Architecture

The human ALDOA gene is located on chromosome 16q24.3 and spans approximately 7.5 kb, containing 9 exons. Alternative splicing generates two isoforms: the predominant isoform 1 (364 amino acids, ~39 kDa) expressed in all tissues, and isoform 2 (359 amino acids) which lacks 5 amino acids near the C-terminus and is enriched in red blood cells. The 5' untranslated region contains conserved regulatory elements that mediate tissue-specific expression, including a muscle-specific enhancer and a red cell-specific promoter. ALDOA assembles into a homotetramer (α4) under physiological conditions; tetramerization is essential for catalytic activity and stability. Monomeric ALDOA is catalytically inactive and prone to aggregation. Two other aldolase isoforms exist in humans: ALDOB (liver type, chromosome 9q31.2) and ALDOC (brain type, chromosome 17q11.2). The three isoforms share approximately 65-70% amino acid sequence identity, with conservation of the active site lysine residue (Lys146 in ALDOA, equivalent to Lys229 in ALDOB). Tissue-specific expression of these isoforms reflects their distinct metabolic roles: ALDOA for general glycolysis, ALDOB for fructose metabolism and gluconeogenesis, and ALDOC for brain-specific carbohydrate metabolism.

Alternate Names for ALDOA

ALDOA; aldolase A, fructose-bisphosphate; fructose-bisphosphate aldolase A; muscle-type aldolase;